The Future of Risk Communication and the Role of the Pharmaceutical Industry
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Current drug safety - 8(2013), 1 vom: 1. Feb., Seite 4-10 |
| Beteiligte Personen: |
Chakraborty, Sweta [VerfasserIn] |
|---|
| Umfang: |
7 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1921539755 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1921539755 | ||
| 003 | DE-627 | ||
| 005 | 20230511165201.0 | ||
| 007 | tu | ||
| 008 | 130603s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw130602_1 |
| 035 | |a (DE-627)OLC1921539755 | ||
| 035 | |a (DE-599)GBVOLC1921539755 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Chakraborty, Sweta |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Future of Risk Communication and the Role of the Pharmaceutical Industry |
| 264 | 1 | |c 2013 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Bouder, Frederic |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d Sharjah : Bentham Science, 2006 |g 8(2013), 1 vom: 1. Feb., Seite 4-10 |w (DE-627)517812185 |w (DE-600)2250840-5 |w (DE-576)435514229 |x 1574-8863 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2013 |g number:1 |g day:1 |g month:02 |g pages:4-10 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2013 |e 1 |b 1 |c 2 |h 4-10 |g 7 | ||